“Ask About Aspirin” campaign targets maternal cardiovascular challenges in Virginia
Research shows that approximately 1 in 3 pregnancy-related deaths in the U.S. are caused by cardiovascular problems.1 This is in part due to the 15% to 30% increase in heart rate that occurs during the first trimester of pregnancy, which contributes to an increase in cardiac output.2 Low-dose aspirin has emerged as a preventive measure for reducing cardiovascular risks for pregnant individuals. Commonly used to prevent blood clots, aspirin is recognized for its ability to help prevent heart attacks and strokes.3 UnitedHealthcare Community Plan of Virginia supports Virginia Department of Medical Assistance Services’ (VA DMAS) “Ask About Aspirin” campaign which encourages members to speak with their providers about taking aspirin.
"Ask About Aspirin"
VA DMAS, Virginia’s Medicaid program, underwent its largest expansion in 2019 to over 1.5 million Virginians.4 In its effort to improve health outcomes, VA DMAS launched the “Ask About Aspirin” campaign, which focuses on the benefits of low-dose aspirin in addressing cardiovascular symptoms during pregnancy. The campaign provides easy-to-understand infographics that highlight risk factors for maternal heart disease and offer resources for those seeking more information.
Low-dose aspirin has additionally been found to prevent or delay preeclampsia, a severe form of high blood pressure that often develops after 20 weeks of pregnancy.5 Preeclampsia poses serious risks, not only during pregnancy, but also later in life, as individuals with a history of the condition have a two- to four-fold higher risk of developing hypertension and heart disease.6 For these individuals, the “Ask About Aspirin” campaign encourages proactive measures to reduce long-term cardiovascular risks.
By promoting conversations between patients and health care providers, the campaign aims to reduce the incidence of maternal heart disease and improve outcomes for expectant persons. UnitedHealthcare Community & State proudly supports this initiative and the promotion of maternal health education and preventive care for cardiovascular challenges during pregnancy.
